Mohammad Shujauddin Siddiqui, MD | |
10769 Hole Ave, Suite 220, Riverside, CA 92505-2808 | |
(951) 358-5554 | |
(951) 358-5980 |
Full Name | Mohammad Shujauddin Siddiqui |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 10769 Hole Ave, Riverside, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033265665 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | A63496 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mohammad Shujauddin Siddiqui, MD 10769 Hole Ave, Suite 220, Riverside, CA 92505-2808 Ph: (951) 358-5554 | Mohammad Shujauddin Siddiqui, MD 10769 Hole Ave, Suite 220, Riverside, CA 92505-2808 Ph: (951) 358-5554 |
News Archive
Women in the developing world need new methods of contraception that meet their needs and lifestyles, according to a Guttmacher Institute report that urges more investment in contraceptive technology, Agence France-Presse reports.
Climate change may be accelerating rates of chronic kidney disease caused by dehydration and heat stress, according to research appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
A treatment for dry eye-a burning, gritty condition that can impair vision and damage the cornea-could some day result from computer simulations that map the way tears move across the surface of the eye.
This study used DNA sequencing to examine an outbreak of MRSA in a hospital, to uncover new cases and, as the study developed, to intervene in the outbreak to end it more quickly. Sequencing illuminated each person infected and described the transmission of MRSA between people coming to the hospital and within the hospital.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
› Verified 6 days ago
Iris Figueroa Lois, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6405 Day St, Riverside, CA 92507 Phone: 951-697-5432 Fax: 951-697-5471 | |
Dr. Stacy Marie Catalon, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 19314 Jesse Ln, Riverside, CA 92508 Phone: 951-782-3640 | |
Dr. Hisham Ahmad Labanieh, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 951-353-2000 | |
Beth L. Drake, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Iduru Seshadri, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Thomas J Chen, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 7117 Brockton Ave, Riverside, CA 92506 Phone: 951-782-3849 Fax: 951-784-3271 |